| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
2 companies
Ho Carole is a Chief Medical Officer at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 3,743 | $13.81 | $51,684.30 | -0.9% | +18.7% | - | |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 15,162 | $20.33 | $308,290.77 | -4.1% | -45.2% | -20.0% | |
| Aug 21, 2024 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22,458 | $24.49 | $549,927.77 | -5.5% | -2.6% | -39.1% | |
| Aug 13, 2024 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,337 | $22.89 | $53,493.93 | -1.6% | +37.2% | -35.7% | |
| Feb 14, 2024 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 4,189 | $17.46 | $73,130.31 | -1.4% | +10.4% | +19.1% | |
| Jan 10, 2024 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 4,668 | $19.02 | $88,785.36 | -3.1% | +3.5% | +1.6% | |
| Jan 5, 2024 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 9,972 | $19.43 | $193,755.96 | -4.8% | -1.8% | +9.9% | |
| Aug 23, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,522 | $23.22 | $58,560.84 | -1.4% | -20.0% | +5.0% | |
| Aug 21, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,478 | $22.60 | $56,002.80 | -1.3% | -17.5% | +1.6% | |
| Aug 14, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,768 | $23.79 | $65,850.72 | -1.5% | -33.7% | -5.8% |